TODDE, SERGIO CAMILLO
TODDE, SERGIO CAMILLO
11C-Labelling of N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors
2005 Turolla, Ea; Matarrese, M; Belloli, S; Moresco, Rm; Simonelli, P; Todde, S; Fazio, F; Magni, F; Galli Kienle, M; Leopoldo, M; Berardi, F; Colabufo, Na; Lacivita, E; Perrone, R
11C-Radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]zofenoprilat
2004 Matarrese, M; Salimbeni, A; Turolla, Ea; Turozzi, D; Moresco, Rm; Poma, D; Magni, F; Todde, S; Rossetti, C; Sciarrone, Mt; Bianchi, G; Kienle, Mg; Fazio, F
Assessing cancer metabolic remodeling in animal models using PET imaging
2013 Raccagni, I; Gaglio, D; Valtorta, S; Belloli, S; Di Grigoli, G; Vanoni, M; Mastroianni, F; Todde, S; Alberghina, L; Moresco, R M
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies.
2010 Matarrese M. ; Bedeschi P. ; Scardaoni R. ; Sudati F. ; Savi A. ; Pepe A. ; Masiello V. ; Todde S. ; Gianolli L. ; Messa C. ; Fazio F.
Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time
2006 Calandrino, R; del Vecchio, A; Savi, A; Todde, S; Griffoni, V; Brambilla, S; Parisi, R; Simone, G; Fazio, F
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models
2023 Rainone P.; Valtorta S.; Villa C.; Todde S.; Cadamuro M.; Bertoli G.; Conconi D.; Lavitrano M.; Moresco R.M.
Evaluation of Radiotherapy associated with Temozolomide plus Metformin in a GBM immunocompetent microenvironment
2021 Salvatore, D; Valtorta, S; Bertoli, G; Todde, S; Iannone, M; Coliva, A; Toninelli, E; Spinelli, A; Zerbetto, F; Villa, S; Di Muzio, N; Moresco, R
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.
2010 Elsinga P ; Todde S ; Penuelas I ; Meyer G ; Farstad B ; FaivreChauvet A ; Mikolajczak R ; Westera G ; GmeinerStopar T ; Decristoforo C ; Radiopharmacy Committee of the EANM.
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma
2021 Valtorta, S; Lo Dico, A; Raccagni, I; Martelli, C; Pieri, V; Rainone, P; Todde, S; Zinnhardt, B; De Bernardi, E; Coliva, A; Politi, Ls; Viel, T; Jacobs, Ah; Galli, R; Ottobrini, L; Vaira, V; Moresco, Rm
Improved synthesis and radiolabeling of [(11)C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET
2006 Carpinelli, A; Magni, F; Cattaneo, A; Matarrese, M; Turolla, E; Todde, S; Bosso, N; Galli Kienle, M; Fazio, F
In vivo imaging of adenosine A2a receptors in rat and primate brain using [11C]SCH442416.
2005 Moresco, Rm; Todde, S; Belloli, S; Simonelli, P; Panzacchi, A; Rigamonti, M; Gallikienle, M; Fazio, F
Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons
2010 Calandrino, R; del Vecchio, A; Parisi, R; Todde, S; De Felice, P; Savi, A; Pepe, A; Mrskova, A
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation.
2008 Moresco R.M. ; Lavazza T. ; Belloli S. ; Lecchi M. ; Pezzola A. ; Todde S. ; Matarrese M. ; Carpinelli A. ; Turolla E. ; Zimarino V. ; Popoli P. ; Malgaroli A. ; ;Fazio F.
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approac
2022 Iannone M.N.; Stucchi S.; Turolla E.A.; Beretta C.; Ciceri S.; Chinello C.; Pagani L.; Todde S.; Ferraboschi P.
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach
2021 Iannone, Mn; Stucchi, S; Turolla, Ea; Beretta, C; Ciceri, S; Chinello, C; Pagani, L; Todde, S; Ferraboschi, P
Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography.
2007 Filannino M.A. ; Matarrese M. ; Turolla E.A. ; Masiello V. ; Moresco R.M. ; Todde S. ; Verza E. ; Magni F. ; Cattaneo A. ; Bachi A. ; Kienle M.G. ; Fazio F.
The evaluation of [18F]FDG and [18F]FLT radiotracers as potential biomarkers of early treatment outcome in triple negative breast cancer (TNBC)
2021 Rainone P.; Valtorta S.; Todde S.; Salvatore R.; Moresco R.M.
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells
2015 Curtarello M.; Zulato E.; Nardo G.; Valtorta S.; Guzzo G.; Rossi E.; Esposito G.; Msaki A.; Pasto A.; Rasola A.; Persano L.; Ciccarese F.; Bertorelle R.; Todde S.; Plebani M.; Schroer H.; Walenta S.; MuellerKlieser W.; Amadori A.; Moresco R.M.; Indraccolo S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 11C-Labelling of N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors | 1-gen-2005 | Turolla, Ea; Matarrese, M; Belloli, S; Moresco, Rm; Simonelli, P; Todde, S; Fazio, F; Magni, F; Galli Kienle, M; Leopoldo, M; Berardi, F; Colabufo, Na; Lacivita, E; Perrone, R | |
| 11C-Radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]zofenoprilat | 1-gen-2004 | Matarrese, M; Salimbeni, A; Turolla, Ea; Turozzi, D; Moresco, Rm; Poma, D; Magni, F; Todde, S; Rossetti, C; Sciarrone, Mt; Bianchi, G; Kienle, Mg; Fazio, F | |
| Assessing cancer metabolic remodeling in animal models using PET imaging | 1-gen-2013 | Raccagni, I; Gaglio, D; Valtorta, S; Belloli, S; Di Grigoli, G; Vanoni, M; Mastroianni, F; Todde, S; Alberghina, L; Moresco, R M | |
| Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies. | 1-gen-2010 | Matarrese M. ; Bedeschi P. ; Scardaoni R. ; Sudati F. ; Savi A. ; Pepe A. ; Masiello V. ; Todde S. ; Gianolli L. ; Messa C. ; Fazio F. | |
| Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time | 1-gen-2006 | Calandrino, R; del Vecchio, A; Savi, A; Todde, S; Griffoni, V; Brambilla, S; Parisi, R; Simone, G; Fazio, F | |
| Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models | 1-gen-2023 | Rainone P.; Valtorta S.; Villa C.; Todde S.; Cadamuro M.; Bertoli G.; Conconi D.; Lavitrano M.; Moresco R.M. | |
| Evaluation of Radiotherapy associated with Temozolomide plus Metformin in a GBM immunocompetent microenvironment | 1-gen-2021 | Salvatore, D; Valtorta, S; Bertoli, G; Todde, S; Iannone, M; Coliva, A; Toninelli, E; Spinelli, A; Zerbetto, F; Villa, S; Di Muzio, N; Moresco, R | |
| Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. | 1-gen-2010 | Elsinga P ; Todde S ; Penuelas I ; Meyer G ; Farstad B ; FaivreChauvet A ; Mikolajczak R ; Westera G ; GmeinerStopar T ; Decristoforo C ; Radiopharmacy Committee of the EANM. | |
| Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma | 1-gen-2021 | Valtorta, S; Lo Dico, A; Raccagni, I; Martelli, C; Pieri, V; Rainone, P; Todde, S; Zinnhardt, B; De Bernardi, E; Coliva, A; Politi, Ls; Viel, T; Jacobs, Ah; Galli, R; Ottobrini, L; Vaira, V; Moresco, Rm | |
| Improved synthesis and radiolabeling of [(11)C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET | 1-gen-2006 | Carpinelli, A; Magni, F; Cattaneo, A; Matarrese, M; Turolla, E; Todde, S; Bosso, N; Galli Kienle, M; Fazio, F | |
| In vivo imaging of adenosine A2a receptors in rat and primate brain using [11C]SCH442416. | 1-gen-2005 | Moresco, Rm; Todde, S; Belloli, S; Simonelli, P; Panzacchi, A; Rigamonti, M; Gallikienle, M; Fazio, F | |
| Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons | 1-gen-2010 | Calandrino, R; del Vecchio, A; Parisi, R; Todde, S; De Felice, P; Savi, A; Pepe, A; Mrskova, A | |
| Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation. | 1-gen-2008 | Moresco R.M. ; Lavazza T. ; Belloli S. ; Lecchi M. ; Pezzola A. ; Todde S. ; Matarrese M. ; Carpinelli A. ; Turolla E. ; Zimarino V. ; Popoli P. ; Malgaroli A. ; ;Fazio F. | |
| Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approac | 1-gen-2022 | Iannone M.N.; Stucchi S.; Turolla E.A.; Beretta C.; Ciceri S.; Chinello C.; Pagani L.; Todde S.; Ferraboschi P. | |
| Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach | 1-gen-2021 | Iannone, Mn; Stucchi, S; Turolla, Ea; Beretta, C; Ciceri, S; Chinello, C; Pagani, L; Todde, S; Ferraboschi, P | |
| Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography. | 1-gen-2007 | Filannino M.A. ; Matarrese M. ; Turolla E.A. ; Masiello V. ; Moresco R.M. ; Todde S. ; Verza E. ; Magni F. ; Cattaneo A. ; Bachi A. ; Kienle M.G. ; Fazio F. | |
| The evaluation of [18F]FDG and [18F]FLT radiotracers as potential biomarkers of early treatment outcome in triple negative breast cancer (TNBC) | 1-gen-2021 | Rainone P.; Valtorta S.; Todde S.; Salvatore R.; Moresco R.M. | |
| VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells | 1-gen-2015 | Curtarello M.; Zulato E.; Nardo G.; Valtorta S.; Guzzo G.; Rossi E.; Esposito G.; Msaki A.; Pasto A.; Rasola A.; Persano L.; Ciccarese F.; Bertorelle R.; Todde S.; Plebani M.; Schroer H.; Walenta S.; MuellerKlieser W.; Amadori A.; Moresco R.M.; Indraccolo S. |